Abstract
Efforts to identify potent small molecule inhibitors of PI3 kinase and mTOR led to the discovery of the exceptionally potent 6-aryl morpholino thienopyrimidine 6. In an effort to reduce the melting point in analogs of 6, the thienopyrimidine was modified by the addition of a methyl group to disrupt planarity. This modification resulted in a general improvement in in vivo clearance. This discovery led to the identification of GNE-477 (8), a potent and efficacious dual PI3K/mTOR inhibitor.
Copyright 2010 Elsevier Ltd. All rights reserved.
MeSH terms
-
Animals
-
Dogs
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacokinetics
-
Enzyme Inhibitors / pharmacology*
-
Female
-
Intracellular Signaling Peptides and Proteins / antagonists & inhibitors*
-
Mice
-
Phosphoinositide-3 Kinase Inhibitors*
-
Protein Serine-Threonine Kinases / antagonists & inhibitors*
-
Pyrimidines / chemistry
-
Pyrimidines / pharmacology*
-
Rats
-
TOR Serine-Threonine Kinases
-
Thiophenes / chemistry
-
Thiophenes / pharmacology*
Substances
-
Enzyme Inhibitors
-
GNE 477
-
Intracellular Signaling Peptides and Proteins
-
Phosphoinositide-3 Kinase Inhibitors
-
Pyrimidines
-
Thiophenes
-
mTOR protein, mouse
-
Protein Serine-Threonine Kinases
-
TOR Serine-Threonine Kinases